Core Insights - The surgical robotics industry is experiencing a surge in collaborations with NVIDIA, with over 8 surgical robotics companies announcing partnerships to integrate NVIDIA's advanced AI and robotics platforms into their systems [1][2] - NVIDIA's IGX Thor platform, featuring 5581 FP4 TFLOPS AI computing power and 400GbE network capabilities, represents a significant leap in computational efficiency and perception capabilities compared to previous platforms [1][9] - Companies like EndoQuest Robotics and CMR Surgical are among the first to adopt the IGX Thor platform, aiming to enhance their robotic systems' performance and capabilities [1][10] Collaboration with NVIDIA - EndoQuest Robotics plans to integrate NVIDIA's IGX Thor platform into its next-generation surgical robot [2] - CMR Surgical has become one of the first global adopters of the IGX Thor platform [2] - Other companies such as Johnson & Johnson, XCath, Asensus, Moon Surgical, Virtual Incision, Neptune Surgical, and Stereotaxis have also formed partnerships with NVIDIA to leverage its technology [1][2] Innovations in Automation and Intelligence - Domestic companies like MicroPort, Precision Medical, and Tianzhihang have already introduced surgical robots equipped with advanced imaging, intelligent navigation, surgical planning, and decision support features [3] - Companies like GeroTech have showcased fully automated surgical solutions, achieving higher levels of automation in surgical procedures [3][4] - The collaboration with NVIDIA is expected to further enhance the capabilities of these robots, particularly in real-time perception and decision-making [12] Computational Power as a Foundation - The demand for computational power in surgical robotics is increasing due to the growing complexity of algorithms and clinical requirements [5] - NVIDIA's solutions are seen as essential for meeting the computational needs for real-time environment perception, data processing, and multi-modal data integration [5][6] - The need for high computational power is critical for pre-operative, intra-operative, and post-operative functionalities [6][7] Competitive Landscape - The partnerships with NVIDIA may enable these surgical robotics companies to compete more effectively with established players like Intuitive Surgical's da Vinci system [9][12] - The IGX Thor platform's capabilities, such as enhanced AI vascular recognition and low-latency control, provide a competitive edge for companies like CMR Surgical [10] - The integration of NVIDIA's platforms is expected to accelerate the development of innovative surgical robots, potentially reshaping the competitive landscape [12][14] Future Directions and Challenges - The surgical robotics industry is moving towards greater automation and intelligence, but challenges such as data availability, regulatory hurdles, and ethical considerations remain [15] - The collaboration with NVIDIA is anticipated to play a crucial role in overcoming these challenges and driving innovation in the field [12][15] - The shift towards software-driven and computationally powered surgical robots is expected to continue, with a focus on enhancing automation and intelligence [14][15]

MedRobot 近日 直观医疗I ntui tive （纳斯达克股票代码： ISRG )频繁被分析师提及——收购经销商、关税问 题的影响等等。 尽管面临供应链挑战， 直观医疗Intuitive（纳斯达克股票代码： ISRG )的新一代手术机器人系统达芬奇5在 2024年取得了显著的成绩。根据公司年度财报数据显示，自2024年3月推出以来，全球共安装了362台达芬奇5 系统，其中174台在第四季度完成安装。全年共有超过2500名外科医生使用该系统完成了32000多例手术，充分 体现了机器人辅助手术的强劲需求。 装机量破万！收入612亿！达芬奇最新财报！ 直观医疗 首席执行官Gary Guthart近日在电话会议上透露了更多信息： # 回顾2024年 全面推出达芬奇5（2024年是针对部分老客户限量销售）；（MedRobot备注：这似乎是在说，既 然关税导致成本压力大，那就努力卖价格更高的达芬奇5） 达芬奇5：价格上涨30%，更多细节见内 ； 最新！达芬奇5数据应用方向大揭秘 顶级设计！直击达芬奇5代机器人新亮点 在美国、德国、保加利亚增加工厂； 开展直销、 增强培训等 等。 收购经销商！达芬奇撸起袖子自己干 ...